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Increased Severity of Bleomycin-Induced Skin
Fibrosis in Mice with Leukocyte-Specific Protein 1
Deficiency
JianFei Wang1, Haiyan Jiao1, Tara L. Stewart1, Heather A. Shankowsky1, Paul G. Scott3 and
Edward E. Tredget1,2
Fibrosis is a complex process resulting from persistent inflammation following tissue damage. It involves the
interaction of numerous cell types, soluble mediators, and extracellular matrix. Recently, a newly identified
cell type, the fibrocyte, has been reported to contribute to wound healing and to fibrotic conditions such
as hypertrophic scarring. Previously, we established leukocyte-specific protein 1 (LSP1) as a new marker for
fibrocytes. In the present study, we examined the biological role of LSP1 in the development of skin fibrosis
using bleomycin in an Lsp1/ mice. These animals showed a significant increase in fibrosis, with increased
thickness of the skin and collagen content. The skin in Lsp1/ mice injected with bleomycin had higher
densities of neutrophils, macrophages, and fibrocytes. In accordance with the increased leukocyte infiltration,
the expression levels of macrophage-derived chemokines, transforming growth factor-b1, and connective tissue
growth factor were all upregulated in Lsp1/ mice. These results demonstrate that the absence of LSP1
promotes fibrosis in the skin. The most likely mechanism for this effect seems to be through an increase in
leukocyte infiltration, leading to locally elevated synthesis and the release of chemokines and growth factors.
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INTRODUCTION
Inflammation and fibrosis are interrelated conditions with
many overlapping mechanisms (Lupher and Gallatin, 2006).
Macrophages, T lymphocytes, and myofibroblasts have all
been reported to play important roles in both processes
(Wynn, 2004). After tissue injury, an inflammatory stimulus is
necessary to initiate tissue repair, where cytokines released
from resident and infiltrating leukocytes stimulate the
proliferation and activation of fibroblasts. However, in many
disease states and sometimes following minimal trauma,
tissue repair becomes severely dysregulated and results in
fibrosis, which is characterized by excessive accumulation of
extracellular matrix (ECM) proteins at the injured sites (Knapp
et al., 1977; Hunt et al., 1990). Myofibroblasts are thought to
contribute to fibrosis by providing contractile force and
synthesizing ECM (Darby and Hewitson, 2007). In addition,
myofibroblasts can take on the role of traditional antigen-
presenting cells, secreting pro-inflammatory cytokines,
recruiting inflammatory cells to fibrotic foci, and amplifying
the fibrotic response in a vicious cycle (Lupher and Gallatin,
2006). Therefore, myofibroblasts play a pivotal role in
inflammation and the fibrosis process. These cells are usually
believed to be derived from resident fibroblasts under the
influence of profibrotic growth factors such as transforming
growth factor-b (TGF-b) (Desmouliere et al., 2005). Recent
reports have demonstrated that some myofibroblasts in
fibrotic conditions appear to be derived from the bone
marrow (Yamaguchi et al., 2007) or to directly differentiate
from circulating fibrocytes (Metz, 2003; Mori et al., 2005).
Fibrocytes are a novel cell population that represents
0.1–0.5% of peripheral blood leukocytes (Bucala et al., 1994;
Quan et al., 2004). Fibrocytes are thought to play a role in
tissue repair by several mechanisms, such as the secretion of
ECM components, antigen presentation, cytokine production,
angiogenesis, and wound closure (Metz, 2003). They have
been reported to be associated with various fibrotic condi-
tions (Quan et al., 2006). Recently, we have reported an
increase in the number of fibrocytes in recovering burn
patients and in post-burn hypertrophic scars (Yang et al.,
2002; Yang et al., 2005), and that fibrocytes may contribute
to scarring by regulating the activities of fibroblasts (Wang
et al., 2007c). Fibrocytes have been characterized by the
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expression of collagen type I, fibronectin, CD11b, CD34, and
CD45 (Quan et al., 2004). Unfortunately, these cell surface
proteins are not unique to fibrocytes. For example, CD34 is
also found on capillary endothelial cells. Moreover, some of
these markers, including CD34 and CD45, are gradually lost
in culture (Phillips et al., 2004). To identify a more stable and
specific marker for fibrocytes, we performed two-dimen-
sional gel electrophoresis and mass spectrometry, which
resulted in the identification of LSP1 as a potential marker for
fibrocytes (Yang et al., 2005). More importantly, LSP1 is
completely absent from fibroblasts, and therefore, dual
immunostaining for procollagen type I and LSP1 can be used
to identify fibrocytes and distinguish them from fibroblasts
(Wang et al., 2007b).
LSP1 is a 52-kDa intracellular F-actin-binding protein that
accumulates on the cortical cytoskeleton. It is expressed in
mature and immature B and T cells, macrophages, and
neutrophils (Jongstra-Bilen and Jongstra, 2006). LSP1 has two
putative Ca2þ -binding motifs and is found in three different
subcellular fractions (Jongstra-Bilen et al., 1992). LSP1 is a
substrate for mitogen-activated protein kinase activated
protein kinase 2 and for protein kinase C (Jongstra-Bilen
and Jongstra, 2006), two enzymes implicated in leukocyte
migration and chemotaxis. In addition, LSP1 was also
reported to regulate a Ca2þ -dependent step in the induction
of anti-IgM-mediated apoptosis (Jongstra-Bilen et al., 1999).
Therefore, LSP1 appears to be a signaling molecule that
regulates cytoskeletal architecture and mobility and plays a
role in receptor-induced apoptosis.
Because LSP1 is predominantly expressed by leukocytes
and fibrocytes, and inflammation plays a pivotal role in
fibrosis, elucidating the role of LSP1 in skin fibrosis is of
interest. In this study, we examined the biological relevance
of LSP1 to skin fibrosis development using Lsp1/ mice in
which subcutaneous injection of bleomycin produces a
dermal lesion that is histologically and biochemically similar
to that seen in scleroderma (Yamamoto et al., 1999;
Yamamoto and Nishioka, 2005). Skin fibrosis was signifi-
cantly increased in Lsp1/ mice. Recruitment of neutrophils,
macrophages and fibrocytes during the inflammatory phase
was significantly increased in the Lsp1/ mice compared
with wild-type (WT) mice. Corresponding to the increased
recruitment of inflammatory cells to the bleomycin lesional
sites, collagen synthesis was also enhanced. In accordance
with these observations, the expression levels of macrophage-
derived chemokines and growth factors were also upregu-
lated. The results presented here suggest that LSP1 regulates
skin fibrosis by mediating leukocyte recruitment and that the
subsequent production of chemokines and growth factors
ultimately results in aggravated fibrosis.
RESULTS
Histologic comparison of bleomycin-induced lesions in WT and
Lsp1/ mice
The accumulation and organization of dermal collagen and
the degree of fibrosis were compared between WT and
Lsp1/ mice that received injections of bleomycin. The
sections were subjected to Masson’s trichrome stain, which
permits the areas of mature collagen deposition to be
detected. Skin lesions in both WT and Lsp1/ mice treated
with bleomycin showed dense accumulations of thick
collagen bundles in the dermis, reflecting increased collagen
deposition. There was a replacement of subcutaneous fat by
connective tissue in WT mice (Figure 1a). However, the
bleomycin injection sites from Lsp1/ mice developed
significantly more dermal fibrosis, and the subcutaneous fat
was completely replaced by connective tissue (Figure 1b).
Moreover, the lesional dermis contained a marked increase
in leukocyte infiltration, predominantly localized to the
deeper layer in Lsp1/ bleomycin-injected skin (Figure
1d), when compared with WT bleomycin-injected skin
(Figure 1c).
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Figure 1. Histological assessment of bleomycin-induced lesions in WT and
Lsp1/ mice. Photomicrographs of the bleomycin-injected sites from WT
(a, c) and Lsp1/ mice (b, d). Lesional skin was harvested and examined by
histology. Representative sections stained with either Masson’s trichrome
staining (upper panel) or hematoxylin and eosin (H&E) (lower panel) are
shown (original magnification  100). (e) Dermal thickness was measured in
five randomly selected sites/field for the PBS-injected sites (left side) and the
bleomycin-injection sites (right side) in both WT (open bars) and Lsp1/
(filled bars) mice. Results are expressed as the mean±SE, **Po0.0001, N¼ 5,
scale bar¼ 50mm.
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To quantify fibrosis, dermal thickness was measured.
In WT mice, the dermal thickness of bleomycin lesions
was increased 1.4-fold compared with control phosphate-
buffered saline (PBS)-injected sites (292.3 vs 215.3mm,
Po0.001) (Figure 1e). In contrast, in Lsp1/ mice, bleomy-
cin induced an even greater increase in dermal thickness
(Figure 1d). Compared with WT mice, bleomycin injection in
Lsp1/ mice resulted in a maximal 1.6-fold increase in
dermal thickness compared with PBS-treated controls (429.9
vs 277.2mm, Po0.00001) (Figure 1e). Therefore, the fibrotic
response induced by bleomycin was significantly increased
in Lsp1/ mice compared with the WT control.
Elevated expression of type I collagen and HSP47 in the lesion
sites of Lsp1/ mice
To assess collagen content, we measured hydroxyproline in
tissue samples from the injected sites. The hydroxyproline
content in wet weight samples was significantly higher in
both WT (149.1 vs 109.1mgmg1, Po0.04) and Lsp1/
mice (181.3 vs 105.2mgmg1, Po0.0008) treated with bleo-
mycin compared with PBS. Interestingly, the hydroxyproline
content in bleomycin-treated Lsp1/ mice was significantly
higher than that in WT mice (181.3 vs 149.1 mgmg1,
Po0.003) (Figure 2a). The levels of collagen type 1 a1
(COL1a1) mRNA were examined by real-time reverse trans-
cription-PCR analysis (Figure 2b). Not surprisingly, the level
of COL1a1 mRNA was significantly higher in bleomycin-
injected skin in both WT and Lsp1/ mice; however, the
level of COL1a1 mRNA was significantly higher in Lsp1/
mice than in WT mice injected with bleomycin (Figure 2b).
Figure 2c indicates more than a two- and four-fold increases
in HSP47 mRNA levels in bleomycin-injected WT and
Lsp1/ mice, respectively.
Upregulated TGF-b1 and CTGF levels in the lesion sites of
Lsp1/ mice
TGF-b1 and connective tissue growth factor (CTGF) are two
growth factors that have been reported to coordinately
regulate the development of fibrosis (Leask, 2004; Leask
and Abraham, 2004). As shown in Figure 3a, mRNA levels for
TGF-b1 in both WT and Lsp1/ mice receiving bleomycin
are significantly upregulated (2.2- and 3.5-fold, Po0.0007
and o0.001, respectively). The pattern of change in mRNA
levels for CTGF (Figure 3b) is similar to that for TGF-b1. WT
and LSP1/ mice receiving bleomycin had significantly
more mRNA for CTGF (1.7 and 2.4, Po0.002 and 0.008,
respectively) compared with PBS-injected controls. For both
TGF-b1 and CTGF, the increases were significantly greater in
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Figure 2. Collagen mRNA, protein and HSP47 mRNA levels in the
lesion sites. Comparison of collagen content as assessed by measuring
hydroxyproline from the lesion sites of WT (open bars) and Lsp1/ (filled
bars) mice the after injection of PBS or bleomycin for 2 weeks (a). Real-time
PCR analysis of the expression of COL1a1 (b) and HSP47 (c) genes in the
lesions of WT (open bars) and Lsp1/ mice (filled bars). All data are
expressed as mean±SE (N¼ 5) (*Po0.05; **Po0.01).
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Figure 3. TGF-b and CTGF expression in the lesion sites. WT and Lsp1/
mice received subcutaneous injections of PBS or bleomycin every other day
for 2 weeks. The lesional skin was collected for the measurement of mRNA
levels of TGF-b (a) and CTGF (b) in WT (open bars) and Lsp1/ (filled bars)
mice by real-time PCR. Sections of the lesional skin from WT and Lsp1/
mice were subjected to immunohistochemical staining with anti-TGF-b
antibody in bleomycin-injected WT (c) and Lsp1/ (d) mice, and with anti-
CTGF antibody in bleomycin-injected WT (e) and Lsp1/ mice (f). All data
are expressed as mean±SE (N¼ 5, *Po0.05; **Po0.01), scale bar¼ 50 mm.
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bleomycin-injected Lsp1/ mice than in WT mice. Immuno-
histochemical staining for TGF-b1 in WT (Figure 3c) and
Lsp1/ (Figure 3d) mice, and for CTGF in WT (Figure 3e) and
Lsp1/ (Figure 3f) mice, showed increased protein levels
consistent with the real-time PCR results for mRNA levels.
Increased inflammatory cells and myofibroblasts in the
lesion sites of Lsp1/ mice
When compared with WT mice, bleomycin-treated skin
samples from Lsp1/ mice had significantly more macro-
phages (79.2±5.1 vs 38.6±3.5 cells per high-power field
(HPF), Po0.0007) (Figure 4a). Lesions from the Lsp1/ mice
also contained significantly more neutrophils than those from
the WT mice (14.3±1.4 vs 9.6±0.8 cells per HPF, Po0.009)
(Figure 4b). In contrast to macrophages and neutrophils, the
number of CD3-positive T cells was not significantly increa-
sed in the bleomycin-injected skin from WT or Lsp1/ mice
(Figure 4c). No differences between WT and Lsp1/ mice
were seen in the number of neutrophils, macrophages, or
T cells in the control sites that had been injected with PBS.
Increased myofibroblast accumulation in the dermis is a
key finding in scleroderma and is thought to contribute to the
pathogenesis (Darby and Hewitson, 2007). Myofibroblasts
were examined by staining the skin with a-smooth muscle
actin (a-SMA). In the normal skin, a-SMA was observed
exclusively in blood vessels and in erector pili muscles (data
not shown). a-SMA-positive cells at other sites were also rare
in the area of PBS injection in both WT and Lsp1/ mice
(data not shown). At the bleomycin injection sites, how-
ever, myofibroblasts were consistently found throughout the
dermis of both WT and Lsp1/ mice (Figure 5a and b),
significantly more (20 vs 12 cells per HPF, Po0.001) in the
Lsp1/ mice (Figure 5c).
Increased number of fibrocytes in the lesion sites
of Lsp1/ mice
Fibrocytes have been associated with a variety of fibrotic
conditions (Quan et al., 2006). When tissue samples were
stained for cells co-expressing CD13 and pro-collagen type 1
(Mori et al., 2005), numerous fibrocytes were visualized and
where they appear primarily around or adjacent to micro-
vessels (Figure 6a). Results show increased fibrocyte numbers
for both WT and Lsp1/ mice treated with bleomycin,
whereas very few fibrocytes were detected in PBS-injected
mouse skin (Figure 6b). However, the number of fibrocytes in
bleomycin-injected Lsp1/ mouse skin (18.5±2.4) was
significantly higher than that in bleomycin-injected WT
mouse skin (10.3±4.9) (Po0.001).
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Figure 4. Quantitative analysis of inflammatory cells in lesions of WT and
Lsp1/ mice. Histologic sections of lesional skin from WT and Lsp1/
mice were subjected to immunohistochemical staining with (a) anti-F4/80
(macrophage marker), (b) anti-Gr-1 (neutrophil marker), and (c) anti-CD3
(T-cell marker) antibodies. The number of positive cells was counted in five
high-power fields per section. All data expressed as the mean±SE (N¼ 5,
*Po0.05; **Po0.01).
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Figure 5. Quantification of myofibroblasts in lesional skin from WT and
Lsp1/ mice. a-SMA staining was performed on tissue sections from
bleomycin treated WT (a) and Lsp1/mice (b). Representative
photomicrographs are shown from five animals per group. The number of
positive cells was counted in five high-power fields per section. In WT mice,
the bleomycin-treated sites contained few a-SMA-positive cells. In contrast,
the bleomycin-treated sites from Lsp1/ mice consistently exhibited a-SMA-
positive cells throughout the dermis (c). All data are expressed as mean±SE
(N¼5, *Po0.05). Original magnification 200, scale bar¼25 mm.
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Increased expression of chemokines at the lesion sites in
LSP1/ mice
To compare the expression of chemokines at the lesion sites,
real-time PCR and ELISA were performed to analyze
monocyte chemoattractant protein-1, macrophage inflamma-
tory protein alpha (MIP-1a), and MIP-2 (Figure 7). The mRNA
and protein levels for these chemokines were all significantly
higher in the Lsp1/ lesion sites compared with the WT
lesion sites. The increased expression of these chemokines in
the Lsp1/ lesion sites is consistent with the increased
infiltration of neutrophils and macrophages.
DISCUSSION
Skin sclerosis is intimately associated with protracted
inflammation (Yamamoto and Nishioka, 2005). Thus, in
monocyte chemoattractant protein-1-deficient mice,
bleomycin-induced skin fibrosis is much diminished
compared with WT mice due to fewer leukocytes infiltrating
to the lesional site, resulting in less inflammation (Ferreira
et al., 2006). LSP1, a cytoskeleton protein, has been reported
to be a negative regulator of leukocyte emigration in
inflammation (Jongstra-Bilen et al., 2000; Jongstra-Bilen and
Jongstra, 2006). More recently, we have observed that wound
closure is significantly accelerated in Lsp1/ mice, con-
comitant with the increased number of leukocytes and fibro-
cytes (Wang et al., 2007a). In the present study, we have
demonstrated an increased skin fibrosis in the bleomycin-
injected sites of LSP1-deficient mice, which is associated with
an increased number of leukocytes and fibrocytes.
The results of our study on bleomycin-induced fibrosis and
inflammation in Lsp1/ mice are generally consistent with
the previous published work. In vitro, the expression of high
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Figure 6. Quantification of fibrocytes in the lesion sites. Cryosections of skin samples from WT and Lsp1/ mice after receiving PBS or bleomycin
injection for 2 weeks were stained for CD13 and for type I procollagen I by immunofluorescence and examined by confocal microscopy (a). Fibrocytes
were quantified by an algorithm, which was designed using MetaMorph Image Software as described in the Materials and Methods section (b). The data
represent the mean±SE (n¼ 4, *Po0.05). Scale bar¼ 5 mm.
www.jidonline.org 2771
JF Wang et al.
LSP1 Function in Skin Fibrosis
levels of LSP1 in normally LSP1-deficient melanoma or U937
cells diminished cell motility (Howard et al., 1998; Li et al.,
2000). Similarly, in hairy cell leukemia, the overexpression of
LSP1 in neutrophils inhibits leukocyte migration and increa-
ses cell adhesion, leading to recurrent infection (Miyoshi
et al., 2001). Injecting thioglycollate into the peritoneum
and zymosan into knee joints showed increased leukocyte
infiltration in the Lsp1/ mice (Jongstra-Bilen et al., 2000).
We have previously observed an increased leukocyte
infiltration in the LSP1-deficient mice in an excisional wound
model (Wang et al., 2007a).
The combined effects of physiological differences in
microvasculature and the integrins involved may dictate
organ-specific roles for LSP1 in leukocyte recruitment into the
inflammatory sites. The requirement for LSP1 in neutrophil
chemotaxis is dependent on the type of integrin engaged
(Jongstra-Bilen and Jongstra, 2006). Mac-1 (CD11b/CD18;
aMb2) is negatively regulated by LSP1 (Wang et al., 2002).
Optimal levels of integrin-mediated adhesion by focal
contacts are critical for stabilizing the polarization of
leukocytes during chemotaxis. Indeed, on fibrinogen gel,
which is a b2 integrin substrate used by leukocytes, in
addition to increased adhesion and migration rate, LSP1/
neutrophils exhibit more robust fMLP-induced polarization of
F-actin and increased focal contacts at the anterior and
expanded trailing filopodia at the posterior of the cell.
Deficiency of LSP1 may upregulate the expression of Mac-1,
which in turn speeds up leukocyte recruitment.
LSP1 is known to be involved in the recruitment of
monocytes and the activation of macrophages (Jongstra-Bilen
et al., 2000), and therefore it is anticipated that bleomycin
injections would elicit a higher accumulation of macrophages
in the lesional skin of Lsp1/ mice compared with WT mice.
These findings are consistent with previous observations of
skin injury, where wounds in LSP1-deficient mice resulted in
an increased number of macrophage in dermal wounds
(Wang et al., 2007a). Together, the results support the concept
that LSP1 plays a pivotal role by controlling mononuclear cell
recruitment and macrophage activation. The recruited macro-
phages via the production of pro-fibrotic cytokines, such as
TGF-b and CTGF, may then augment matrix production,
fibroblast proliferation, and myofibroblast differentiation
(Yamamoto and Nishioka, 2003).
A growing body of evidence indicates the crucial
involvement of chemokines in leukocyte infiltration (Gillitzer
and Goebeler, 2001). Our findings demonstrate that the
expression of several chemokines, such as monocyte chemo-
attractant protein-1, MIP-1a, and MIP-2, was increased at the
lesional sites in Lsp1/ mice. The most likely explanation for
this observation is that the neutrophils and macrophages
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Figure 7. Quantification of chemokine expression of bleomycin-induced lesions in WT and Lsp1/ mice. Expression of chemokines in injected skin as
assessed by real-time PCR for mRNA levels for MCP-1 (a), MIP-1a (b), and MIP-2 (c) and by ELISA for protein levels for MCP-1 (d), MIP-1a (e), and MIP-2
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recruited into the lesion site are themselves the major source
of these chemokines during the lesion development. These
chemokines could, in turn, stimulate even more leukocytic
infiltration.
The presence of myofibroblasts is consistent with the
pathology of fibrotic diseases (Sappino et al., 1990; Ludwicka
et al., 1992). Myofibroblasts are specialized cells with high
synthetic capacity for ECM proteins, such as collagen, as well
as fibrogenic cytokines and chemokines (Hinz, 2007). In
bleomycin-induced skin fibrosis, we observed that in addition
to the increased presence of myofibroblasts, the levels of
TGF-b and CTGF were higher in lesional skin of the Lsp1/
mice. The initial increase in these two profibrotic growth
factors may result from the increased infiltration of macro-
phages and fibrocytes. These two growth factors may then act
in a paracrine manner to stimulate fibroblasts to produce
more TGF-b and CTGF, to differentiate into myofibroblasts,
and thus to sustain the fibrotic process.
The modulation of inflammation by LSP1 is important to the
fibrotic response. When comparing WT and Lsp1/ mice, the
differences in matrix organization and collagen fibrillogenesis
at the site of bleomycin injection were striking. In bleomycin-
treated WT mice, a dermal thickening exhibited a collagen
arrangement that was near-normal in appearance. In contrast,
in Lsp1/ mice, the robust dermal thickening was associated
with highly disorganized and primarily small-diameter fibers,
an architecture associated with fibrotic reactions involving
rapid ECM accumulation (Kischer, 1974; Kahari, 1993; Lakos
et al., 2004). These observations suggest that LSP1 mediates a
sequence of events that ultimately results in the deposition of
excess collagen with fibers that are smaller than in normal
skin. In addition, our results also revealed that the accumula-
tion of collagen observed in the bleomycin-treated skin from
WT and Lsp1/ mice is accompanied by the upregulation of
HSP47 mRNA expression. Because HSP47 plays an important
role in collagen biosynthesis (Nagata, 1996), this change may
contribute to the increased synthesis and altered assembly of
collagen.
Blood-borne cells that are rapidly recruited into wound
chambers in mice adopt a spindle shape and synthesize
collagen, which were identified in 1994 and termed
fibrocytes (Bucala et al., 1994). These cells exhibit characteri-
stics of both fibroblasts and monocytes. Theoretically,
fibrocytes could potentially express markers, such as CD14,
CD34, CD45, CXCR4, CCR3, 5, 7, CD11b, CD18, and
vimentin (Bellini and Mattoli, 2007). However, whether those
markers could be useful to localize fibrocytes in tissue section
remains to be investigated. Others and we have noticed that
markers such as CD14, CD34, and CD45 gradually disappear
during long-term in vitro culture, and thus making long-term
use of these markers to track fibrocytes difficult (Phillips et al.,
2004; Wang et al., 2007b). We have shown that LSP1 is
stably expressed by fibrocytes for at least 2 months, whereas
CD34 and CD45 become almost undetectable (Wang et al.,
2007b). Moreover, fibroblasts do not express LSP1. Therefore,
dual immunostaining for procollagen I and LSP1 can be used
to identify fibrocytes, and to distinguish them from fibroblasts
and other leukocytes in tissue sections (Yang et al., 2005).
Fibrocytes have been reported to be also a source of
myofibroblasts and contribute to wound closure and fibrotic
conditions (Phillips et al., 2004; Mori et al., 2005). Fibro-
cytes, identified by their staining for CD34, have been
reported in various experimental and naturally occurring
fibrotic conditions, including bleomycin-induced pulmonary
fibrosis (Phillips et al., 2004), renal fibrosis (Okada and
Kalluri, 2005), and liver fibrosis (Kisseleva et al., 2006). In
this study, the number of fibrocytes in LSP1-deficient
bleomycin-injected skin was significantly higher than in WT
mice. The increased fibrocyte numbers probably resulted
from an increased monocyte infiltration after bleomycin
injection-resulted lesion, because fibrocytes are a subpopula-
tion of leukocytes and derived from peripheral mononuclear
cells (Abe et al., 2001). Therefore, the current study indicates
that the increased fibrosis in Lsp1/ mice is also associated
with an increased number of fibrocytes in the inflamed sites.
The present findings demonstrate a markedly increased
response to fibrotic stimulus in the absence of LSP1. To our
knowledge, this is the first report that LSP1 plays a regulatory
role in skin fibrosis by regulating leukocyte infiltration.
Further analysis of Lsp1/ mice may lead to improved
therapies for skin and other fibrotic diseases.
MATERIALS AND METHODS
Animals
129/SvJ WT mice were purchased from the Jackson Laboratory (Bar
Harbor, ME). Lsp1/ mice on the 129/SvJ background were
generated by homologous recombination as described previously
(Jongstra-Bilen et al., 2000) and transferred from the University of
Calgary Health Sciences Centre to the University of Alberta Health
Science Laboratory Animal Services facility. Lsp1/ mice were bred
and used between 8 and 10 weeks of age. All animal protocols were
approved by the Animal Care and Use Committee of the University of
Alberta and met the standards of the Canadian Association of Animal
Care. All animals were kept in specific pathogen-free conditions.
Bleomycin treatment
Bleomycin (Mayne Pharma Inc., Montreal, Quebec, Canada) was
diluted to 5mgml1 with PBS, sterilized, and filtered. Using a
27-gauge needle, 100ml of bleomycin or PBS was injected
subcutaneously into a single location on the shaved back of Lsp1/
and WT mice once every other day for 2 weeks. At the end of the
experiment, mice were euthanized by CO2.
Histological analyses of dermal thickness
Skin samples were obtained from the injection sites, fixed in 4%
paraformaldehyde and embedded in paraffin. Sections (5mm) were cut,
mounted on slide, and stained with hematoxylin and eosin or with
Masson’s trichrome. Dermal thickness was measured in HE sections
viewed under  100 magnification by measuring the distance between
the epidermal–dermal junction and the dermal–fat junction in five
randomly selected fields in two or more sections from each animal.
Analysis of inflammatory cell infiltrate
Immunohistochemistry was performed on frozen sections as
described previously (Tredget et al., 2006). Skin samples
were embedded in Shandon Cryomatrix (Thermo Electron Corp.,
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Pittsburgh, PA) and 8 mm sections were cut, fixed in acetone, treated
with hydrogen peroxide to quench endogenous peroxidase, and
blocked with corresponding serum from a secondary antibody raised
for 1 hour. Slides were then incubated for 2 hours at room
temperature with rat anti-mouse Ly-6G (Gr-1) mAb (10 mgml1;
eBioscience Inc., Hornby, ON) or with rat anti-mouse F4/80 mAb
(5mgml1; eBioscience Inc., San Diego, CA), or hamster anti-mouse
CD3 biotin-labeled antibody (5mgml1; eBioscience Inc., San
Diego, CA) for the identification of neutrophils, macrophages, or
T lymphocytes, respectively. Sections that were incubated with rat
anti-Gr-1 or anti-F4/80 antibodies were subsequently incubated with
anti-rat antibody conjugated with horseradish peroxidase (Sigma, St
Louis, MO). The sections that had been incubated with anti-CD3
antibody were incubated with streptavidin conjugated with horse-
radish peroxidase (Dako, Mississauga, ON, Canada). The signals on
the tissue were revealed using diaminobenzidine and hydrogen
peroxide. Thereafter, counterstaining was performed with hema-
toxylin. A blinded observer counted F4/80-positive macrophages,
Gr-1-positive neutrophils, or CD3-positive T lymphocytes in skin
tissue in five random HPF ( 200) of each section (Low et al., 2001).
Quantification of fibrocytes
To detect fibrocytes, cryosections (8mm) were subjected to analysis
following previously published work, with minor modification (Mori
et al., 2005). Briefly, the slides were fixed with 4% paraformalde-
hyde, quenched for autofluorescence with 0.1% glycine in PBS, and
then blocked with corresponding serum from a secondary antibody
raised for 1 hour . After washing, tissue sections were incubated
overnight at 4 1C with a rat anti-mouse CD13 (Serotec, Raleigh, NC)
followed by TRITC-conjugated goat anti-rat (Jackson ImmunoRe-
search, West Grove, PA). Subsequently, slides were incubated with
an anti-mouse collagen I antibody (Chemicon, Temecula, CA)
overnight at 4 1C followed by FITC-conjugated goat anti-rabbit
antibody. Cell nuclei were detected by incubating the tissue sections
with Draq5 (Alexis Biochemicals, San Diego, CA) for 10minutes.
After washing, tissue sections were mounted using 50% PBS–50%
glycerol containing 4mgml1 of n-propyl gallate (Sigma-Aldrich,
Oakville, ON, Canada). Cryosections were examined using a
LSM510 laser scanning confocal microscope at 489 nm to assess
collagen I, 543 nm to assess CD13, and 688nm to assess cell nuclei.
To quantify fibrocytes, an algorithm was designed using MetaMorph
Image Software (Metamorph, Molecular Devices Corporation,
Sunnyvale, CA) using positive nuclear staining, dual fluorescence,
and cell size as criteria for the inclusion (Wang et al., 2007a).
Hydroxyproline analysis
The content of collagen in injected skin tissue was determined by
mass spectrometric analysis of 4-hydroxyproline (Yang et al., 2001;
Wang et al., 2007c). Injected skin samples taken from WT and
Lsp1/ mice were freeze-dried. An internal standard (N-methyl-L-
proline) and a 6 N HCl solution were added to wound tissue, and
each sample was then hydrolyzed overnight at 115 1C. The O-butyl
ester derivatives were prepared with 10% BF2-butanol for 30minutes
at 120 1C after drying the hydrolysate. Liquid chromatography
(column: Eclipse XDB-C18)/mass spectrometry analysis was per-
formed on a Hewlett-Packard (series 1100, Atlanta, GA) mass
selective detector monitoring the ions at m/z 186 and 188.
RNA isolation and real-time reverse transcription-PCR
Total RNA extraction from injected skin samples and real-time
reverse transcription-PCR for chemokine analysis was performed as
described previously (Wang et al., 2007a). Amplification of the
housekeeping gene b-actin mRNA was used as to normalize results.
The primers used are listed in Table 1. mRNA levels were measured
as CT threshold levels and normalized with the individual b-actin
control CT values. Altered mRNA levels in bleomycin-injected skin
are expressed as fold changes relative to those in WT PBS-injected
skin.
Measurement of chemokine protein by ELISA
Injected skin samples were homogenized at 2,600 r.p.m. using a
Mikro-Dismembrator (Braun Biotech International, Allentown, PA)
in 200 ml of lysis buffer (10mM PBS, 0.1% Triton X-100, and 5mM
EDTA) containing complete protease inhibitor mixture (Sigma) to
extract the proteins. The homogenates were incubated on ice,
vortexed intermittly, and then the debris was removed by
centrifugation at 14,000 r.p.m. The supernatant was applied to
ELISA to measure protein for monocyte chemoattractant protein-1
(eBioscience, San Diego, CA), MIP-1a and MIP-2 (Antigenix Inc.,
Huntington Station, NY) according to the manufacturer’s recom-
mendation. Total protein in the supernatant was measured with a
commercial kit (Bio-Rad Laboratories Inc., Hercules, CA). The data
were expressed as chemokines (ngmg1) of total protein for each
sample.
Table 1. Sequences of primers for real-time PCR
Gene Forward primer Reverse primer
b-Actin 50-ACGGCCAGGTCATCACTATTG-30 50-CAAGAAGGAAGGCTGGAAAAGA-30
Collagen a1 50-ATTCGGACTAGACATTGG-30 50-GGGTTGTTCGTCTGTTTC-30
HSP47 50-TGGTGCGAGATAATCAGAGC-30 50-TCATCTCGCATCTTGTCTCC-30
TGF-b1 50-TGTTAAAACTGGCATCTGA-30 50-GTCtCTTAGGAAGTAGGT-30
CTGF 50-GAGTGTGCACTGCCAAAGAT-30 50-GGCAAGTGCATTGGTATTTG-30
MCP-1 50-CCCGTAAATCTGAAGCTAA-30 50-CACACTGGTCACTCCTACAGAA-30
MIP-1 50-CCAGTCCCTTTTCTGTTC-30 50-CTTGGTTGCAGAGTGTCAT-30
MIP-2 50-GGCTAACTGACCTGGAAAGG-30 50-GCACATCAGGTACGATCCAG-30
CTGF, connective tissue growth factor; HSP, heat shock protein; MCP-1, monocyte chemotactic protein-1; TGF-b1, transforming growth factor-b1.
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Detection of myofibroblasts in WT and LSP1/ mouse tissue
The lesional skin from WT and Lsp1/ mice was embedded in
paraffin. Sections (5 mm) were cut, dewaxed, and stained with a
rabbit antibody for a-SMA (NeoMarkers Inc., Fremont, CA). Briefly,
dewaxed and hydrated sections were quenched with H2O2 (3%) and
blocked with 10% goat serum. The slides were then incubated with
2mgml1 of rabbit anti-mouse a-SMA antibody at 4 1C overnight.
After washing, the slides were incubated with a goat anti-rabbit
antibody conjugated with horseradish peroxidase (Sigma-Aldrich).
The signals on the tissues were revealed using diaminobenzidine
with hydrogen peroxide. Thereafter, counterstaining was performed
with hematoxylin. A blinded observer examined at least three HPFs
per section. The relative levels of a-SMA-positive cells in the lesional
bleomycin-injected sites were described in comparison with the
levels in the control PBS-injected sites.
Statistical analysis
All experiments were carried out in triplicate or quadruplicate. Data
are expressed as mean±SEM. Statistical analysis was performed
using analysis of variance with the Tukey–Kramer multiple compa-
risons, with significance set at Po0.05.
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